Latest Updates

Over 150 participating exhibitors from all over India and estimated to attract 4500+ visitors

Will form a Joint Program Committee to implement prevention, awareness and education, testing and treatment, and health systems…

Industry lauds the GST Bill

It brought together drug safety experts from the lifesciences industry with an aim to discuss pharmacovigilance issues that are…

Believes it will allow for better quality of clinical research in India and benefit patients

The portfolio being acquired comprises complex generic products across diverse dosage forms

Industry experts give their viewpoint on key taxation reform bill GST

Winner in the ‘Healthcare’ and ‘Not-For-Profit’ category

The two companies align to provide capabilities and solutions to deliver end-to-end support for renal disease clinical trials

The Lexington site capabilities and capacity would be expanded for commercial aseptic manufacturing

The commercial launch of these tablets in the US is expected over the next few weeks

Galvani will develop miniaturised, implantable devices that can modify electrical nerve signals to modulate irregular or altered…

With this acquisition, Kyowa will rank sixth amongst generic companies in Japan

Acquires controlling interest in Nashik-based Klasspack

Until recently, Upadhye was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy’s

Net revenues up by 16 per cent Q-o-Q

Profit After Tax (PAT) was reported at Rs 19.8 crores

A nationwide HCV awareness campaign was organised across Tier-I and Tier-II cities

Net sales for the quarter came in at Rs 685 crores, recording a growth of eight per cent GlaxoSmithKline Pharmaceuticals declared…